doi: 10.1016/j.clinre.2016.11.009 Summary Keywords glucagon-like peptide-1 receptor agonists, metabolic disease, metabolic dysfunction-associated steatotic liver disease, public health, umbrella review Citation Wu H, Zhang Z-H, Ye T, Chen J-N, Tung T-H and Zhu J-S (2026) Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review
2020;5:e140532
choice depends on individual profile, goals, and budget
Targets stubborn dark circles and under-eye puffiness with the Tranexamic Acid + Glutathione Eye Cream, formulated to visibly brighten and smooth the delicate eye area
Endocrine regulation of gut function a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome
GLP-1 weight loss prescriptions Wegovy, Rybelsus, Saxenda, Ozempic and Zepbound specialized medications that require injection are the single biggest driver of employer health costs, adding 1% to the total premium expense for 2025, according to data released last fall from the benefits consultancy Aon